GLP-1 RAs are linked to an increased risk of NAION in type 2 diabetes patients, with semaglutide and liraglutide showing significant associations. The study involved over 3.8 million Medicare patients ...

“Ischemia” is the term doctors use when a part of the body stops getting enough oxygen as a result of restricted blood flow. This is because blood carries oxygen in the body. In the case of NAION, ...

In response to a small number of postmarketing reports of vision loss in men taking type 5 phosphodiesterase (PDE-5) inhibitors, the US Food and Drug Administration (FDA) has issued a news release to ...

Plaintiff Todd Engel pictured with his wife and daughter. A Maryland man who has lost his vision due to non-arteritic anterior ischaemic optic neuropathy (NAION) is suing Novo Nordisk, alleging that ...

People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, doctors say it shouldn’t deter patients from using the medicines to treat ...

Nonarteritic anterior ischemic optic neuropathy (NAION) is significantly associated with persistently elevated risk for stroke, independent of typical cardiovascular risk factors, a large ...

A new observational study on Wednesday reported for the first time a potential link between Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision loss. After hearing ...

Parker Waichman, a national law firm, has now filed multiple lawsuits where each Plaintiff alleged that he or she developed NAION after taking Novo Nordisk's Ozempic. Parker Waichman continues to file ...

Please provide your email address to receive an email when new articles are posted on . Nonarteritic anterior ischemic optic neuropathy risk was 2.33 times higher with semaglutide. Clinicians need to ...

One of just nine voucher recipients chosen and the only one in the eye space, the selection spotlights Dompé’s dedication to accelerate innovation and deliver breakthrough therapies to patients who ...